Jiayan Yan

1.0k total citations · 1 hit paper
27 papers, 552 citations indexed

About

Jiayan Yan is a scholar working on Molecular Biology, Electrical and Electronic Engineering and Hepatology. According to data from OpenAlex, Jiayan Yan has authored 27 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Electrical and Electronic Engineering and 5 papers in Hepatology. Recurrent topics in Jiayan Yan's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Microbial Natural Products and Biosynthesis (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Jiayan Yan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Microbial Natural Products and Biosynthesis (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Jiayan Yan collaborates with scholars based in China, Australia and United States. Jiayan Yan's co-authors include Huaihe Song, Xiaohong Chen, Shubin Yang, Chenghui Zhou, Lun–Xiu Qin, Le Zhu, Deliang Fu, Bo Kong, Qiongzhu Dong and Xiaoqiang Zhu and has published in prestigious journals such as ACS Catalysis, Electrochimica Acta and Frontiers in Immunology.

In The Last Decade

Jiayan Yan

27 papers receiving 548 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives

2021 220 citations Shun Wang, Yan Zheng et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiayan Yan China	12	209	191	132	97	63	27	552
Yi‐Fu Huang China	15	309 1.5×	161 0.8×	76 0.6×	68 0.7×	22 0.3×	30	618
Shiquan Li China	15	274 1.3×	68 0.4×	162 1.2×	79 0.8×	30 0.5×	50	579
Lingxin Meng China	12	171 0.8×	182 1.0×	109 0.8×	95 1.0×	79 1.3×	27	542
Yu‐Ching Lin Japan	13	435 2.1×	100 0.5×	64 0.5×	62 0.6×	26 0.4×	39	741
Rong Zheng China	12	214 1.0×	44 0.2×	66 0.5×	113 1.2×	44 0.7×	19	489
Chaoxiong Zhang China	16	282 1.3×	146 0.8×	183 1.4×	160 1.6×	19 0.3×	31	914
Huijin Li China	16	337 1.6×	47 0.2×	258 2.0×	222 2.3×	39 0.6×	47	809
Sadegh Dehghani Iran	15	589 2.8×	160 0.8×	125 0.9×	84 0.9×	29 0.5×	21	982
Jiameng Liu China	10	344 1.6×	67 0.4×	104 0.8×	89 0.9×	13 0.2×	23	543
Zan Liu China	15	281 1.3×	60 0.3×	134 1.0×	51 0.5×	43 0.7×	40	560

Countries citing papers authored by Jiayan Yan

Since Specialization

Citations

This map shows the geographic impact of Jiayan Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayan Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayan Yan more than expected).

Fields of papers citing papers by Jiayan Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayan Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayan Yan. The network helps show where Jiayan Yan may publish in the future.

Co-authorship network of co-authors of Jiayan Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayan Yan. A scholar is included among the top collaborators of Jiayan Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayan Yan. Jiayan Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yan, Jiayan, Shiyu Zhang, Qichao Yu, et al.. (2025). Spatial‒temporal heterogeneities of liver cancer and the discovery of the invasive zone. Clinical and Translational Medicine. 15(2). e70224–e70224. 2 indexed citations

Reading, Christopher L., Jiayan Yan, Marcia A. Testa, et al.. (2025). An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease. Frontiers in Neuroscience. 19. 1516746–1516746. 1 indexed citations

Guo, De‐Zhen, Xin Zhang, Shiyu Zhang, et al.. (2024). Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts. Molecular Cancer. 23(1). 157–157. 22 indexed citations

Yan, Jiayan, Yunying Li, Hongju He, et al.. (2024). Effects of electron beam irradiation on the sensory qualities and bioactive compounds of broccoli sprout juice. Food Research International. 199. 115365–115365. 4 indexed citations

Zhang, Junzhe, Si Gao, Qin‐Qin Li, et al.. (2023). Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification. World Journal of Surgical Oncology. 21(1). 239–239. 4 indexed citations

Guo, De‐Zhen, Shiyu Zhang, Jiayan Yan, et al.. (2023). Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy. Frontiers in Oncology. 13. 1109742–1109742. 6 indexed citations

Guo, De‐Zhen, Shiyu Zhang, Jiayan Yan, et al.. (2023). Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy. Frontiers in Immunology. 14. 1141199–1141199. 5 indexed citations

Lu, Yuanyuan, Qianqian Xu, Yarui Liu, et al.. (2023). HMG-CoA reductase inhibitor from the endophytic fungus Colletotrichum Capsici. Natural Product Research. 39(4). 749–757. 2 indexed citations

Yan, Jiayan, et al.. (2023). Whey Protein Hydrolysate Improved the Structure and Function of Myofibrillar Protein in Ground Pork during Repeated Freeze–Thaw Cycles. Foods. 12(16). 3135–3135. 4 indexed citations

10.

Zhang, Xiaotong, et al.. (2023). Effects of Whey Peptides on the Quality of Pork Ball Preprepared Dishes during Repeated Freezing–Thawing. Foods. 12(19). 3597–3597. 4 indexed citations

11.

Yan, Jiayan, et al.. (2022). Hierarchical parallel difference-equalization and channels regrouping based estimation of timing skew for time-interleaved ADCs. Microelectronics Journal. 128. 105564–105564. 2 indexed citations

12.

Du, Jun, Zhiyong Liu, Guangcong Zhang, et al.. (2022). Sorafenib-Loaded Cu2−xSe Nanoparticles Boost Photothermal–Synergistic Targeted Therapy against Hepatocellular Carcinoma. Nanomaterials. 12(18). 3191–3191. 12 indexed citations

13.

Zhang, Junzhe, Jiayan Yan, Ke Liu, et al.. (2022). IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N6-methyladenosine-dependent binding. Frontiers in Oncology. 12. 1035871–1035871. 13 indexed citations

14.

Xu, Xin, Ao Huang, De‐Zhen Guo, et al.. (2022). Integration of Inflammation-Immune Factors to Build Prognostic Model Predictive of Prognosis and Minimal Residual Disease for Hepatocellular Carcinoma. Frontiers in Oncology. 12. 893268–893268. 1 indexed citations

15.

Guo, De‐Zhen, Jianwen Cheng, Jiayan Yan, et al.. (2022). Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria. Annals of Translational Medicine. 10(20). 1091–1091. 5 indexed citations

16.

Wang, Shun, Yan Zheng, Yang Feng, et al.. (2021). The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Signal Transduction and Targeted Therapy. 6(1). 249–249. 220 indexed citations breakdown →

17.

Zhu, Xun Sheng, Pengfei Wang, Y. F. Wang, et al.. (2020). A study of the appropriateness, geometry, size, and fillers boundary restraint on representative volume element in electrical simulation for carbon-based nanocomposites. Materials Today Communications. 25. 101639–101639. 6 indexed citations

18.

Feng, Hao, Huan Tong, Jiayan Yan, et al.. (2020). Genomic Features and Clinical Characteristics of Adolescents and Young Adults With Cholangiocarcinoma. Frontiers in Oncology. 9. 1439–1439. 19 indexed citations

19.

Yan, Jiayan, Jia Jia, Jiao Xue, et al.. (2019). Characterization of the Biosynthetic Gene Cluster for the Antibiotic Armeniaspirols in Streptomyces armeniacus. Journal of Natural Products. 82(2). 318–323. 26 indexed citations

20.

Yan, Jiayan, et al.. (2019). Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression. Journal of Experimental & Clinical Cancer Research. 38(1). 390–390. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact